Jennifer E. Spillane
Queen Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Neonatal Fc receptor (FcRn) inhibition and the implications for inflammatory bowel disease and co-existing immune-mediated diseases.
Journal: Expert review of gastroenterology & hepatology
Published: August 15, 2026
Robotic thymectomy for ocular myasthenia gravis: a case series from a UK tertiary centre.
Journal: BMJ neurology open
Published: October 23, 2025
FcRn inhibitors for myasthenia gravis.
Journal: The Cochrane database of systematic reviews
Published: August 22, 2025
Complement inhibitors for myasthenia gravis in adults.
Journal: The Cochrane database of systematic reviews
Published: July 08, 2025
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.
Journal: Med (New York, N.Y.)
Published: April 23, 2025
Drug treatment for myotonia.
Journal: The Cochrane database of systematic reviews
Published: April 08, 2025
Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines Approach.
Journal: Muscle & nerve
Published: January 24, 2025
Bi-allelic loss-of-function variants in POC5 cause a syndromic retinal, endocrine, and neuromuscular ciliopathy.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 29, 2024
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experience.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 26, 2024
Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.
Journal: Neuromuscular disorders : NMD
Published: December 19, 2023
Last Updated: 09/26/2026